Since 2021, vaccinations for Coronavirus Disease 2019 (COVID-19) are more and more a health policy to cope with on-going pandemic crisis. Is this policy response enough to stop the diffusion of novel coronavirus and reduce the negative impact in society? The goal of this study here is to...

Operation Warp Speed (OWS) was a U.S. government-led program to accelerate the development, production, and administration of COVID-19 vaccines. The program cut the typical ten-year timeline needed to develop a new vaccine down to ten months and began vaccinating vulnerable populations within a...

This article examines how the excise tax affects firm research and development (R&D) investment and performance in the medical device industry in the United States. The Affordable Care Act imposed a 2.3% excise tax on medical devices from January 2013. Using the Compustat data from 2006 and...

Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...

In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmaceutical market. For given prices, RP increases generic firms' expected profit, but since RP also stimulates price competition, the impact on generic entry is theoretically ambiguous. In order to...

The signing of the Free Trade Agreement (FTA) between the governments of Colombia and the United States on 22 November 2006 has generated widespread expectations, both positive and negative, between most actors political and economic landscape of the country. Between expectations of negative...

We study the effect of the COVID-19 pandemic on chronic disease drug adherence. Focusing on asthma, we use a database that tracks the vast majority of prescription drug claims in the U.S. from 2018 to 2020. Using a difference-in-differences empirical specification, we compare monthly drug...

Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...